Identification of autoantigen epitopes in MHC class II transgenic mice

Immunological Reviews

Volumn 164, Issue , 1998, Pages 129-138

  Sønderstrup, Grete ^b   McDevitt, Hugh ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; GENETIC ENGINEERING; GENOTYPE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; EPITOPES; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; IMMUNODOMINANT EPITOPES; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL;

EID: 0031757434     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01215.x     Document Type: Article

References (33)

1. Castano L, Eisenbarth G. Type 1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990;8:647-680.
2. Sercarz EE, et al. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
3. Miller SD, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1033-1136.
4. Milich DR. Immune responses to hepatitis B virus proteins: relevance of the murine model. Semin Liver Dis 1991;11:93-112.
5. Liblau R, Tisch R, Bercovici N, McDevitt HO. Systemic antigen in the treatment of T cell mediated autoimmune disease. Immunol Today 1997;18:599-604.
6. Miller A, Al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993;151:7307-7315.
7. Svejgaard A, Platz P, Ryder LP. HLA and disease 1982 - a survey. Immunol Rev 1983;37:193-218.
8. Winchester, R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
9. Katz JD, Benoist C, Mathis D. T helper subsets in insulin dependent diabetes. Science 1995;268:1185-1188.
10. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease review. Cell 1996;85:311-318.
11. Tisch R, McDevitt HO. Insulin dependent diabetes mellitus. Cell 1996;85:291-297.
12. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-306.
13. Patel SD, et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 using HLA-DR(α1*0101, β1*0401) transgenic mice. Proc Natl Acad Sci USA 1997;94:8082-8087.
14. Fugger L, Rothbard JB, Søonderstrup McDevitt G. The specificity of the dominant HLA-DRB1*0401 restricted T cell response to type II collagen. Eur J Immunol 1996;26:928-933.
15. Killeen N, Sawada S, Littman DR. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J 1993;12:1547-1553.
16. Cosgrove D, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-1066.
17. Hawa M, et al. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type I diabetes. Diabetes 1997;46:1270-1275.
18. Aho K, Paulusuo T, Kurki P. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications. Semin Arthritis Rheum 1994;23:379-387.
19. Verheijden GF, et al. Human cartilage glycoprotein-39 is a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-1125.
20. Johansen JS, Cintin C, Jorgensen M, Kamby C, Price PA. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995;31A:1437-1442.
21. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-25810.
22. Morrison BW, Leder P. Neu and ras initiate murine inflammatory tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-3426.
23. McLaurin JA, Hafler DA, Antel JP. Reactivity of normal T cell lines to MBP isolated from normal and multiple sclerosis white matter. J Neurol Sci 1995;128:205-211.
24. g7 in non-obese diabetic mice. Immunogenetics 1997;46:29-34.
25. Tian J, Lehman PV, Kaufman DL. Determinant spreading of T helper cell responses to pancreatic islet autoantigens. J Exp Med 1997;187:177-183.
26. Singer SM, Tisch R, Yang XD, Sytwu HK, Liblau R, McDevitt HO. Prevention of diabetes in non-obese diabetic mice by a mutated I-A beta transgene. Diabetes (In press).
27. Undlien DE, et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997;46:143-149.
28. Endl J, et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 1996;99:2405-2415.
29. Wicker LS, et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1997;98:2597-2603.
30. Ziegler R, et al. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes 1991;40:709-714.
31. Congia M, Patel SD, Cope AP, De Virgiliis S, Sønderstrup G. The T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from the pro-hormones preproinsulin and proinsulin. Proc Natl Acad Sci USA 1998;95:3833-3838.
32. Von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 1983;133:17-21.
33. Steiner D, James E. Cellular and molecular biology of the beta cell. Diabetologica 1992;35:41-48.